KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Return on Sales (2016 - 2025)

Amgen (AMGN) has 17 years of Return on Sales data on record, last reported at 0.14% in Q4 2025.

  • For Q4 2025, Return on Sales rose 7.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.21%, up 9.0%, while the annual FY2025 figure was 0.21%, 9.0% up from the prior year.
  • Return on Sales reached 0.14% in Q4 2025 per AMGN's latest filing, down from 0.34% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.47% in Q1 2023 and bottomed at 0.02% in Q1 2024.
  • Average Return on Sales over 5 years is 0.21%, with a median of 0.22% recorded in 2025.
  • Peak YoY movement for Return on Sales: grew 23bps in 2023, then tumbled -48bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 0.28% in 2021, then dropped by -15bps to 0.24% in 2022, then tumbled by -60bps to 0.09% in 2023, then dropped by -26bps to 0.07% in 2024, then skyrocketed by 96bps to 0.14% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 0.14% in Q4 2025, 0.34% in Q3 2025, and 0.16% in Q2 2025.